M&A Deal Summary |
|
|---|---|
| Date | 2021-02-18 |
| Target | Vanamali Organics |
| Sector | Life Science |
| Buyer(s) | Wavelength Pharmaceuticals |
| Deal Type | Add-on Acquisition |
SEARCH BY
Wavelength Pharmaceuticals is a developer and manufacturer of generic APIs and finished dose forms (“FDF”) with operations primarily located in Israel and supporting functions in the U.S. and India. The Business has a global customer base and a broad array of products that leverage its specialized manufacturing capabilities and core competency in complex chemistries. Wavelength Pharmaceuticals is based in Petah Tikva, Israel.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| Country: India M&A | 1 of 1 |
| Year: 2021 M&A | 1 of 1 |
